Track topics on Twitter Track topics that are important to you
140 Geary Street Tenth floor
United States of America
Phone: 415 228 3380
Fax: 415 228 3390
CNS-focused Neurana Pharmaceuticals Inc. (formerly Katama) closed a $60mm Series A round led by Sofinnova Ventures. New Leaf Venture Partners, HIG BioHealth Partners, Longitude Capital, and MagnaSci V...
Sofinnova Partners raised its first crossover fund to attract international investors to late-stage EU biotechs.
The life sciences-focused Sofinnova Crossover Fund I was launched by Paris-based venture capital firm Sofinnova Partners afte -More-
Sofinnova invest early in projects with disruptive technologies that have the potential to become strong sustainable companies with the potential to return in excess of 10x their investment. Antoine P...
Sofinnova Partners has launched a crossover fund focusing on European companies to support medical biotechs across all funding stages, from seed to late stage. Sofinnova Partners, the largest French...
After four decades of exclusively backing early stage life science start-ups, French venture capitalist Sofinnova Partners has launched its first...
The round, which was led by HLM Ventures and Optum Ventures, included participation from Centene Corporation, Alma Mundi Ventures and others.
Eko (cardiac monitoring devices) raised $5mm in its Series A financing led by ARTIS Ventures, which was joined by Strategic Partners, Dreamlt Ventures, 1812 Ventures, and founder.org.
B4 Brands: Avant EX Instant Hand Sanitizer
B4 Brands: Avant Foaming Hand Sanitizer - Fragrance Free
B4 Brands: Avant Original Instant Hand Sanitizer
B4 Brands: Aterra Antibacterial Hand Soap
B4 Brands: Avant Original - Fragrance Free Instant Hand Sanitizer
American hospitals are increasingly turning to service outsourcing to reduce costs, including laboratory services. Studies of this practice have largely focused on nonacademic medical centers. In cont...
The Instabul Convention is a normative tool for the prevention of women's violence in Europe. Rome 5 Local Healthcare Authority has implemented a synergistic intervention model in joint ventures with ...
In the science-fiction classic Fantastic Voyage , a shrink-ray zaps a submarine and the crew within it, and the resulting microscopic vehicle ventures inside a human body to destroy a blood clot an...
Opportunities for international missions are highly sought after by medical students, residents, and attending plastic surgeons. The educational benefits and ethical considerations of trainees partici...
Tree nut allergy affects approximately 1.4-2.3%, depending on the study methodology, patient age, and region in which the study was conducted.1,2 Tree nut allergy can be severe, and tends to persist t...
Light microscopy, which is based on century-old technology, remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalaria...
Microscopy remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalarials or in the context of regulatory clinical trial...
Sofinnova Ventures we are company builders who work with our entrepreneurs as a team. Our firm, based in San Francisco and founded in 1974, invests venture capital in early-stage Life Science and Info...
1972 Sofinnova is the first venture capital company created in France.Sofinnova Partners is an independent venture capital company based in Paris. We have special relations with Sofinnova Ventures, o...
NuCanaÂ® is a rapidly growing, clinical stage biopharmaceutical company with a broad development portfolio of novel anti-cancer medicines. The Companyâs proprietary ProTide...
Marinus is a specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders. Marinus ...
Catalyst Biosciences is developing the next generation of biopharmaceuticals by harnessing the catalytic power of engineered proteases that target proteins underlying diseases. Catalyst's discovery p...
We have published hundreds of Sofinnova Ventures news stories on BioPortfolio along with dozens of Sofinnova Ventures Clinical Trials and PubMed Articles about Sofinnova Ventures for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sofinnova Ventures Companies in our database. You can also find out about relevant Sofinnova Ventures Drugs and Medications on this site too.